Fraser Clinical Trials

New Westminster, British Columbia V3L 3W5

3 studies enrolling now · 9 studies all time

What they study most

Cardiovascular Disease, Cardiovascular Diseases, Crohn's Disease, Crohn's Disease (CD), Diabetes Mellitus, Type 2, Heart Failure, Hyperlipidemia, Hypertension, Inflammatory Bowel Disease (IBD), Iron-deficiency, Myocardial Infarction, Non ST Elevation Myocardial Infarction

Studies at this site

• OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction — Completed
• Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry — Completed
• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
• Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease — Completed
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed